Health
How worried should we be about blood clots linked to AstraZeneca, J&J vaccines? – Financial Post
ZURICH — International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they…
Article content
ZURICH International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they investigate reports of extremely rare, but potentially fatal blood clots.
Several EU countries have restricted their use.
Amid concerns that reports of rare side-effects could undermine vaccine confidence, experts have emphasized that clotting risks for both shots remain extremely low and the vaccines are highly effective in…
-
Noosa News22 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business20 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News23 hours agoForum responds to urgent homelessness issues in Nambour
-
General22 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers